188 related articles for article (PubMed ID: 38280071)
1. Head-to-head comparison of [
Aguero C; Dhaynaut M; Amaral AC; Moon SH; Neelamegam R; Scapellato M; Carazo-Casas C; Kumar S; El Fakhri G; Johnson K; Frosch MP; Normandin MD; Gómez-Isla T
Acta Neuropathol; 2024 Jan; 147(1):25. PubMed ID: 38280071
[TBL] [Abstract][Full Text] [Related]
2. Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue.
Aguero C; Dhaynaut M; Normandin MD; Amaral AC; Guehl NJ; Neelamegam R; Marquie M; Johnson KA; El Fakhri G; Frosch MP; Gomez-Isla T
Acta Neuropathol Commun; 2019 Mar; 7(1):37. PubMed ID: 30857558
[TBL] [Abstract][Full Text] [Related]
3. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T
Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase binding not expected to significantly affect [
Wright JP; Goodman JR; Lin YG; Lieberman BP; Clemens J; Gomez LF; Liang Q; Hoye AT; Pontecorvo MJ; Conway KA
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3797-3808. PubMed ID: 35596745
[TBL] [Abstract][Full Text] [Related]
5. Discovery and preclinical characterization of [
Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
[TBL] [Abstract][Full Text] [Related]
6. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases.
Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD
Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172
[TBL] [Abstract][Full Text] [Related]
7. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416
[TBL] [Abstract][Full Text] [Related]
8. [
Marquié M; Agüero C; Amaral AC; Villarejo-Galende A; Ramanan P; Chong MST; Sáez-Calveras N; Bennett RE; Verwer EE; Kim SJW; Dhaynaut M; Alvarez VE; Johnson KA; McKee AC; Frosch MP; Gómez-Isla T
Acta Neuropathol Commun; 2019 Oct; 7(1):164. PubMed ID: 31661038
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Characterization of the Tau PET Tracer [
Harada R; Lerdsirisuk P; Shimizu Y; Yokoyama Y; Du Y; Kudo K; Ezura M; Ishikawa Y; Iwata R; Shidahara M; Ishiki A; Kikuchi A; Hatano Y; Ishihara T; Onodera O; Iwasaki Y; Yoshida M; Taki Y; Arai H; Kudo Y; Yanai K; Furumoto S; Okamura N
J Nucl Med; 2023 Sep; 64(9):1495-1501. PubMed ID: 37321821
[TBL] [Abstract][Full Text] [Related]
10. Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging.
Murugan NA; Chiotis K; Rodriguez-Vieitez E; Lemoine L; Ågren H; Nordberg A
Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1369-1382. PubMed ID: 30919054
[TBL] [Abstract][Full Text] [Related]
11. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
Mohammadi Z; Alizadeh H; Marton J; Cumming P
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830659
[TBL] [Abstract][Full Text] [Related]
12.
Tsai RM; Bejanin A; Lesman-Segev O; LaJoie R; Visani A; Bourakova V; O'Neil JP; Janabi M; Baker S; Lee SE; Perry DC; Bajorek L; Karydas A; Spina S; Grinberg LT; Seeley WW; Ramos EM; Coppola G; Gorno-Tempini ML; Miller BL; Rosen HJ; Jagust W; Boxer AL; Rabinovici GD
Alzheimers Res Ther; 2019 Jan; 11(1):13. PubMed ID: 30704514
[TBL] [Abstract][Full Text] [Related]
13. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
[TBL] [Abstract][Full Text] [Related]
14. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison of tau positron emission tomography tracers [
Smith R; Schöll M; Leuzy A; Jögi J; Ohlsson T; Strandberg O; Hansson O
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):342-354. PubMed ID: 31612245
[TBL] [Abstract][Full Text] [Related]
16. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18.
Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA
J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675
[TBL] [Abstract][Full Text] [Related]
17. Cryptic Sites in Tau Fibrils Explain the Preferential Binding of the AV-1451 PET Tracer toward Alzheimer's Tauopathy.
Murugan NA; Nordberg A; Ågren H
ACS Chem Neurosci; 2021 Jul; 12(13):2437-2447. PubMed ID: 34152739
[TBL] [Abstract][Full Text] [Related]
18. Tau PET Imaging in Neurodegenerative Disorders.
Groot C; Villeneuve S; Smith R; Hansson O; Ossenkoppele R
J Nucl Med; 2022 Jun; 63(Suppl 1):20S-26S. PubMed ID: 35649647
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal 18F-MK-6240 tau tangles accumulation follows Braak stages.
Pascoal TA; Benedet AL; Tudorascu DL; Therriault J; Mathotaarachchi S; Savard M; Lussier FZ; Tissot C; Chamoun M; Kang MS; Stevenson J; Massarweh G; Guiot MC; Soucy JP; Gauthier S; Rosa-Neto P
Brain; 2021 Dec; 144(11):3517-3528. PubMed ID: 34515754
[TBL] [Abstract][Full Text] [Related]
20. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
Lemoine L; Gillberg PG; Svedberg M; Stepanov V; Jia Z; Huang J; Nag S; Tian H; Ghetti B; Okamura N; Higuchi M; Halldin C; Nordberg A
Alzheimers Res Ther; 2017 Dec; 9(1):96. PubMed ID: 29229003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
